Totally three articles focusing on "bone marrow mesenchymal stem cell transplantation under hypothermia, gene-modified bone marrow mesenchymal stem cell transplantation and simple bone marrow mesenchymal stem cell transplantation" are published in three issues. We hope that our readers find these papers useful to their research.

**Abstract**

Following successful establishment of a rat model of spinal cord hemisection injury by resecting right spinal cord tissues, bone marrow stem cells were transplanted into the spinal cord lesions *via* the caudal vein while maintaining rectal temperature at 34 ± 0.5°C for 6 hours (mild hypothermia). Hematoxylin-eosin staining showed that astrocytes gathered around the injury site and formed scars at 4 weeks post-transplantation. Compared with rats transplanted with bone marrow stem cells under normal temperature, rats transplanted with bone marrow stem cells under hypothermia showed increased numbers of proliferating cells (bromodeoxyuridine-positive cells), better recovery of somatosensory-evoked and motor-evoked potentials, greater Basso, Beattie, and Bresnahan locomotor rating scores, and an increased degree of angle in the inclined plate test. These findings suggested that hypothermia combined with bone marrow mesenchymal stem cells transplantation effectively promoted electrical conduction and nerve functional repair in a rat model of spinal cord hemisection injury.
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**Abstract**

Rat bone marrow mesenchymal stem cells expressing brain-derived neurotrophic factor were successfully obtained using a gene transfection method, then intravenously transplanted into rats with spinal cord injury. At 1, 3, and 5 weeks after transplantation, the expression of brain-derived neurotrophic factor and neurofilament-200 was upregulated in the injured spinal cord, spinal cord injury was alleviated, and Basso-Beattie-Bresnahan scores of hindlimb motor function were significantly increased. This evidence suggested that intravenous transplantation of adenovirusmediated brain-derived neurotrophic factor gene-modified rat bone marrow mesenchymal stem cells could play a dual role, simultaneously providing neural stem cells and neurotrophic factors.
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**Abstract**

Non-invasive tracing *in vivo* can be used to observe the migration and distribution of grafted stem cells, and can provide experimental evidence for treatment. This study utilized adenovirus-carrying enhanced green fluorescent protein (AD5/F35-eGFP) and superparamagnetic iron oxide (SPIO)-labeled bone marrow mesenchymal stem cells. Bone marrow mesenchymal stem cells, double-labeled by AD5/F35-eGFP and SPIO, were transplanted into rats with spinal cord injury *via* the subarachnoid space. MRI tracing results demonstrated that bone marrow mesenchymal stem cells migrated to the injured spinal cord over time (T2 hypointensity signals). This result was verified by immunofluorescence. These results indicate that MRI can be utilized to trace *in vivo* the SPIO-labeled BMSCs after grafting.
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